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 Leptospirosis, a zoonosis caused by Leptospira, is recognized as an emergent infectious disease. In 
currently, the lack of adequate diagnostic tools, vaccines are an attractive intervention strategy. In this 
experiment, a 550 bp fragment of large ribosomal RNA gene (16S rRNA) was sequenced and constructed 
phylogenetic tree from a panel of six Vietnamese pathogenic strains of Leptospira spirochetes (e.g., Pomona, 
Canicola, Mitis, Ictero haemohagiae, Bataviae, and Grippotyphosa). The results showed a close relationship of 
L.Pomona_VN and L.Hardjo (bootstrap: 99%). L.Canicola_VN and L.Ictero haemohagiae_VN appeared to be 
weak related to the classic L.Canicola, L. Grippotyphosa, these assemblage have a bootstrap support of 62%. 
The other strains (L.Mitis_VN and L.Grippotyphosa_VN) were appeared monophyletic, while their sister 
group (L.Bataviae_VN) relationship found only weak support (bootstrap: 62%). We also selected six genes 
[e.g. the immunoglobulin like proteins A and B (LigA and LigB genes), outer membrane protein (OmpL1 gene), 
and lipopolysaccharide (LipL32, LipL41, and LipL21 genes)] and checked gene expression in these Leptospira 
strains by polymerase chain reaction (PCR) method. There were three genes (e.g., LipL32, LipL21, and LigA 
genes) expressed in all strains, OmpL1 gene occured in 4 strains (L.Bataviae_VN, L.Canicola_VN, 
L.Grippotyphosa_VN and L.Mitis_VN), whereas LipL41 and LigB genes did not appear in any Leptospira 
strains. A multi-antigenic epitope potential of two gene (Lip L21 and Lip L32) was predicted by bioinformatic 
tools for designing a recombinant vaccine against leptospirosis. There were 3 multi-epitope regions (1 region 
and 95 antigenic epitope for B and T cells of LipL21 peptide; 2 regions and 124 antigenic epitope for both B 
and T cells of LipL32 peptide). It should be more of the deeply molecular biology studies to confirm the level 
agglutinating, antigen cleavage, peptide specificity matrices as well as neutralizing antibodies in the immune 
responses of DNA vaccine of these genes.  
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INTRODUCTION 
 Leptospirosis constitutes an important public 
health problem in developing countries particularly 
those that are impoverished. The disease is 
responsible for economic losses in animal production 
as well as exerts a burden on human health. The 
World Organisation for Animal Health (OIE) 
manages leptospirosis in 2nd group of the most 
dangerous diseases (OIE, 2008) and currently it adds 
to the group of occupational diseases in Vietnam 
(TLĐLĐVN, 1991). Leptospirosis commons 
everywhere in the world, mostly in Africa, South 
America, and Asia regions, causing considerable 
damage to livestock and human health in many 
countries, especially the tropics (Vanasco et al., 
2008). According to the World Health Organization 
(WHO) estimates that there are annually from 7 to 
10 million people in the worldwide infected with the 
Leptospira interrogans (NHS, 2014). In developing 
countries, the disease is mainly farmers and poor 
people in the city, especially, people often working 
outdoors in warm and humid places have the risk of 
infection. The disease transmits to humans through 
mucous, skin, and eyes, which exposure to infected 
animal urine (Slack, 2010). Currently, pathogenic 
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leptospires are classified into nine pathogenic and 
four intermediate species, containing more than 260 
serovars, and six saprophytic species, including over 
60 serovars (Adler, de la Pena Moctezuma, 2010; 
Levett, 2001). The worldwide leptospirosis disease 
burden estimates are hampered by the lack of 
scientifically data from countries with probable high 
endemicity and limited diagnostic capacities. In Sri 
Lanka (2008) 404 possible cases were defined, in 
which 155 were confirmed to have leptospirosis with 
serovars Pyrogenes, Hardjo, Javanica, and 
Hebdomadis (Agampodi et al., 2011). Leptospirosis 
has been prevalent sporadically in China in recent 
years, and Leptospira interrogans 
Icterohaemorrhagiae serovar Lai is the most 
common pathogen in Chinese leptospirosis patients 
and Apodemus agrarius is its major animal host (Hu 
et al., 2014). Nowaday, there are several highlight 
reviews in the leptospirosis, e.g. susceptible 
population, disease transmission and epidemiology, 
treatment, trends and advances in diagnosis, vaccines 
and vaccination strategies in humans and animals. 
Many molecular tools like PCR-RFLP, real-time 
PCR, multiplex PCR, qPCR and immunocapture 
PCR have been found useful for rapid and 
confirmatory detection and differentiation of 
pathogenic and non-pathogenic leptospires to against 
all emerging pathogens with success stories. 
Available vaccines can only provide limited 
protection, which is short lived. The most commonly 
used leptospiral vaccines are based on inactivated 
whole-cell bacterins or leptospiral cell membrane 
components. These preparations although effective, 
are associated with several side-effects like pain, 
irritation and discomfort in addition to limited 
protection. In addition, the vast majority of the 
vaccines are for animal use, albeit for few countries 
that have licensed bacterins for human use (Silveira 
et al., 2017). As a result, the last few decades have 
seen research efforts shifting focus to the classical 
identification of antigens for the development of 
recombinant vaccines against leptospira. While 
significant progress have been recorded, the 
development of a broad-range leptospiral vaccine 
still remains elusive (Dellagostin et al., 2017).  
 The advanced techniques like recombinant DNA 
technology, reverse genetics, DNA vaccination, 
molecular genetics and proteomics approaches are 
being explored for search of novel antigens, proteins 
and genes as potential candidates to discover safer, 
efficient and better vaccines for leptospirosis (Verma 
et al., 2012). The recent advancements of 
recombinant outer membrane protein (OMP) 
vaccines, lipopolysaccharide (LPS) vaccines and 
DNA vaccines against leptospirosis are also 
reviewed (Dellagostin et al., 2011). Moreover, a 
vaccine ontology database was built for the scientists 
working on the leptospirosis vaccines as a starting 
tool (Wang et al., 2007). DNA vaccines containing 
multi-epitope encoded gene have been reported to 
confer protection against many infectious diseases 
(Ding et al., 2012; Sela-Culang et al., 2015; Sette, 
Fikes, 2003). DNA vaccine stimulates antibody 
production in a similar way as foreign antigens are 
processed and presented during natural infection. 
Similarly, multi-epitope DNA vaccines were 
reported to induce more potent immunoreactions 
than whole protein vaccines (Zhao et al., 2012). 
Such vaccines are also able to induce powerful 
cross-reactive immunological response due to the 
fact they are derived from multiple antigens 
packaged into a relatively small chimeric molecule. 
Moreover, immunity induced by multi-epitope DNA 
vaccine includes both the humoral and cellular 
immune component. Hence, they are considered 
suitable for protection against a wide range of 
serovars, especially in endemic regions. The 
construction of such highly complex synthetic 
vaccine may potentially have higher efficacy than 
assembly of naturally occurring sequences (Yu et al., 
2015). Chemically synthesized genes could produce 
a significant impact on the immuno-reactivity 
against diverse leptospiral outer membrane proteins 
(Rollauer et al., 2015; Wang et al., 2002). Overall, 
recognition of special clinical symptoms of 
leptospirosis and determination exactly the target 
immune factors are important not only to have rapid 
diagnosis and treating in time but also to reduce risks 
of fatality by vaccination. 
MATERIALS AND METHODS 
Leptospira strains, cultivation, and serogroup 
identification 
 Among twelve epidemiologically related 
Leptospira strains collected from human or rats in 
Leptospira outbreaks in Vietnam, we selected six 
Leptospira strains that were used to make the 
inactivated vaccine currently in Vietnam, 
including L.Pomona_VN, L.Canicola_VN, 
L.Mitis_VN, L.Ictero haemohagiae_VN, 
L.Bataviae_VN, and L.Grippotyphosa_VN. 
Serogroup identification of these leptospiral 
Journal of Biotechnology 16(4): 745-756, 2018 
747 
strains was carried out by Microscopic 
agglutination test (MAT) with 12 international 
standard serogroup-specific rabbit antisera from 
the National Center for Veterinary Diagnosis 
(NCDV), Vietnam. All of the 6 strains were 
maintained by the NCDV. Leptospires were stored 
long-term at −70°C and have been passaged every 
six months. When needed, they were subcultured 
in 10ml Ellinghausen- McCullough-Johnson-
Harris (EMJH) liquid medium at 30oC for 7-10 
days to stationary phase and checked for the 
presence of contaminating aerobic bacteria by 
overnight culture on 8% (w/v) horse-blood agar at 
30 and 37oC (Ellinghausen, McCullough, 1965). 
Total DNA extraction 
 Genomic DNA was extracted using 
Phenol:Chlorofrom:Isoamyl (25:24:1) (Sambrook, 
Russell, 2001) and was diluted to a final 
concentration of 20 ng/ml. All total DNA samples 
were quality and quantity checks by electrophoresis 
of 3µl of each reaction on 1% agarose gel for 30 min 
at 100V and Nanodrop. 
Sequence assembly and alignment using 16S 
rRNA gene sequencing  
 16S rRNA PCR products (Table 1) were purified 
with mini spin columns provided in GeneJET™ PCR 
Purification Kit (Thermo Fisher Scientific) according 
to the manufacturer’s protocol. The PCR products 
were sequenced according to dideoxynucleotide 
chain termination method (Sanger et al., 1977). 
Sequencing PCR reactions were performed on each 
template on the automated ABI PRISM 3500 DNA 
Sequencer (Applied Biosystems) at Institute of 
Genome Research, Vietnam Academy of Science 
and Technology, Vietnam. Amplified fragments 
were set up in 10 µl reaction volumes (2 µl BigDye 
Terminator v3.1, 1µl BigDye Sequencing buffer, 1 
µl primer (10 µM), 2 µl DNA, and 4 µl water). 
Sequencing was carried out according to the 
following procedure: denaturation at 96oC for 1 min, 
and 25 cycles of denaturation at 96oC for 10 s, 
annealing at 50oC for 5 s, elongation at 60oC for 4 
min. Then the samples were purified and incubated 
with 20 µl Hi-Di, and denatured at 98°C for 2 min. 
Finally, these samples transferred to plate and 
sequenced with the sequencer using POP6 and a 36 
cm capillary array. The run module conditions were 
as follows: 22 s for injection time, 1 kV for injection 
voltage, 15 kV for run voltage, 10 Amps for run 
current, and 55oC for run temperature. 
 
Table 1. Primer pairs used for successful amplification of 16S rRNA sequencing and gene expressions. 
Gene name Sequences Size (bp) Tm 
16S rRNA F GCCTACGGGAGGCAGCAG 550 50oC for 30s 
R CCGTCAATTCMTTTGAGTTT   
OmpL1 F TTGATTGAATTCTTAGAGTTCGTGTTTATA 960 56oC for 50s 
R AAGGAGAAGCTTATGATCCGTAACATAAGT   
LipL32 F TTACCGCTCGAGGTGCTTTCGGTGGTCTGC 782 50oC for 30s 
R TGTTAACCCGGGTTACTTAGTCGCGTCAGA   
LipL41 F AGAGAAGATAATTTTCTCCCCATGGGTAACA 1065 50oC for 50s 
R GAAAGCAACGCAAAGTAACTCGAGTCCTTT   
LipL21 F ATGATCAATAGACTTATAGCTC 560 50oC for 60s 
R TTATTGTTTGGAAACCTCTTGA   
LigA F CGGTCGACTATCGTTACTCCAGCA  991 50oC for 50s 
R CGGCGGCCGCAATATCCGTATTAGA   
LigB F CCGCTCGAGGTGTTTATGAAGAAA  620 50oC for 50s 
R ACTCTCGAGCGTATTAGAGGAAT   
 
Sequencing analysis 
 To explore the genetic diversity and 
evolutionary relationship between the isolates in 
Vietnam and other countries, twenty-four accessible 
Leptospira species reference sequences obtained 
from GenBank database were added into our analysis 
(Table 2). The sequences of all the Leptospira strains 
in this study and the twenty-four representative 
sequences from GenBank were compared using 
CLUSTALW multiple alignments and Phylogenetic 
analysis was conducted with MEGA 6.0. The 
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Maximum Likelihood method based on Kimura 2- 
parameter model was constructed using 
bootstrapping at 1,000 bootstrap replications (Kim et 
al., 2002).  
 
Table 2. Other Leptospira species references from GenBank database. 
Strains Serovar Accession number (NCBI GenBank) 
Leptospira interrogans Hardjo-prajitno  JQ765630.1 
Leptospira interrogans Hardjo-prajitno  CP013147.1 
Leptospira interrogans Hardjo  CP012603.1 
Leptospira interrogans Kennewicki  FJ154571.1 
Leptospira interrogans Pyrogenes DB60 JQ988842.1 
Leptospira interrogans Pomona DB37  JQ988858.1 
Leptospira interrogans Pomona  KR091971.1 
Leptospira interrogans Copenhageni  NR 074524.1 
Leptospira interrogans Copenhageni  KR091970.1 
Leptospira interrogans Linhai  CP006723.1 
Leptospira interrogans Grippotyphosa  JQ906628.1 
Leptospira interrogans Grippotyphosa  JQ906625.1 
Leptospira interrogans Saxkoebing  KR107202.1 
Leptospira interrogans Manilae  CP011931.1 
Leptospira interrogans Canicola  KU053945.1 
Leptospira interrogans Canicola  KR080516.1 
Leptospira interrogans Bratislava  CP011410.1 
Leptospira interrogans Bratislava-DB38  JQ988859.1 
Leptospira interrogans Lai  NR 074481.1 
Leptospira interrogans Australis-DB42  JQ988863.1 
Leptospira interrogans Icterohaemorrhagiae -DB69  JQ988845.1 
Leptospira interrogans Icterohaemorrhagiae  FJ154563.1 
Leptospira interrogans Bataviae-DB59  JQ988841.1 
Leptospira interrogans Muenchen  FJ154565.1 
 
Gene expression 
 Gene expressions were performed based on six 
genes including the immunoglobulin like proteins A 
and B (LigA and LigB genes), outer membrane 
protein (OmpL1 gene), and lipopolysaccharide 
(LipL32, LipL41, and LipL21 genes). The genes were 
amplified in PCR fragments generated with specific 
primer pairs (Table 1). PCR was conducted using the 
following parameters: an initial denature step at 
94°C for 3 min, followed by 30 cycles of 94°C for 
30 - 50 s, 50°C - 56°C for 30 - 50 s, 72°C for 40 - 60 
s, then 72°C for 7 - 10 min. The PCR products were 
visualized on 1% TBE agarose gel electrophoresis 
and ethidium bromide stained to check the gene 
expressions. 
In-silico prediction and selection of vaccine 
epitopes 
 This study used DNA were sequencing from 
six strains of Leptospira by 454 sequencing 
system. ExPASy tool 
(https://web.expasy.org/translate/) was used to 
translate DNA sequence to protein sequence. 
Protein sequences suitable to predict epitope were 
selected by aligning protein sequences on BioEdit 
software (version 7.2.5) (Hall et al., 2011). 
Multiple sequence alignment was done for all 
retrieved sequences using Bioedit software to 
determine the conserved region so as to predict the 
only conserved epitopes that might act as a peptide 
vaccine. In addition, to avoid the epitopes located 
in the signal peptide region, SignalP 3.0 Server 
(http://www.cbs.dtu.dk/services/SignalP/) was 
used to predict the signal peptides. The detection 
of T and B cell epitopes were predicted based on 
the amino acid sequences of LipL21 and LipL32. 
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3D structure prediction 
 I-TASSER Server was used to predict protein 
3D structures (Zhang, 2008). The best results were 
analyzed by ElliPro with default threshold values. 
ElliPro predicts linear and discontinuous antibody 
epitopes based on a protein antigen's 3D structure 
(Ponomarenko et al., 2008). 
B-cell epitope prediction 
 B-cell epitopes were predicted base on sequence 
and structure of LipL21 and LipL32 protein. Protein 
sequence were analyzed by some B-cell prediction 
methods from IEDB including Bepipred Linear 
Epitope Prediction 1.0 & 2.0 (Jespersen et al., 2017; 
Larsen et al., 2006), Chou and Fasman beta turn 
prediction (Chou, Fasman, 2009), Emini Surface 
Accessibility Prediction (Emini et al., 1985), Karplus 
& Schulz Flexibility Prediction (Karplus, Schulz, 
1985), Kolaskar & Tongaonkar Antigenicity 
(Kolaskar, Tongaonkar, 1990) and Parker 
Hydrophilicity Prediction (Parker et al., 1986) with 
default window and threshold values.  
T-cell epitope prediction 
To predict T-cell epitope linked to mayor 
histocompatibility complex (MHC) I or MHC II, the 
IEDB prediction tools were used. This study used 
MHC I Binding tool with all alleles of human, cow, 
mouse and pig (http://tools.iedb.org/mhci), other 
options set default. For MHC II Binding tool, all 
alleles of human and mouse were selected 
(http://tools.iedb.org/mhcii/), other options set 
default. 
Analyzing distribution of epitopes 
Predicted epitopes were aligned with protein 
sequence by Clustal Omega (Sievers et al., 2011). 
Microsoft Excel base on position of epitopes on 
protein sequences to analyze distribution of epitopes. 
 
RESULTS AND DISCUSSION 
Phylogenetic relationship between Vietnamese 
Leptospira strains and other Leptospira strains 
using 16S rRNA gene sequencing 
 Phylogenetic tree was constructed for the six 
leptospiral isolates in this study and the twenty-four 
international pathogenic L. interrogans 
representative strains obtained from GenBank 
database (Figure 1). Sequences 16S rRNA gene of 
Leptospira spp. strains were used for phylogenetic 
analysis. 
 16S rRNA sequencing used as a tool for 
phylogenetic analysis has led to a better 
understanding of evolution of Leptospira. To 
investigate the genetic diversity of leptospirosis, a 
total of six Vietnamese strains and twenty-four 
international reference strains belonging to 
serogroup L.  interrogans were analyzed using 16S 
rRNA gene sequencing. The Maximum Likelihood 
data revealed the phylogenetic relationship between 
these different pathogenic species in this study and 
other international pathogenic species. The findings 
from the phylogenetic tree reveal the relationship 
and genetic diversity of various serovars of 
Leptospira interrogans, with their nearest 
phylogenetic relatives. The results showed that two 
pathogenic species of L.Pomona_VN and L.Hardjo 
seem to be more closely (bootstrap: 99%). A weak 
close genetic relationship of L. Canicola_VN or L. 
Ictero haemohagiae_VN and the classic L.Canicola, 
L.Grippotyphosa was also confirmed by using 16S 
rRNA sequencing in this study (bootstrap: 62%). 
From the phylogenetic analysis, L.Mitis_VN and 
L.Grippotyphosa_VN were clustered together and 
L.Bataviae_VN strain, their sister group, appeared a 
weak phylogenetic relationship (bootstrap: 62%). 
The phylogenetic analysis revealed that the 
genetically diverse strains of serogroup L. 
interrogans isolates from Vietnam were generally 
different with those isolated in other countries. The 
bootstrap percentages quoted are the percentage 
times a taxa at that node occurred, the percentages 
are ranging from 62% to 99%, which may indicate 
that Leptospira may evolve according to different 
locations and the epidemiology of leptospirosis in 
Vietnam relative independent from other countries. 
The genetic relationship of Leptospira species were 
also confirmed by several previous studies. Rettinger 
(2012) compared phylogenetic trees through 16S 
rRNA gene sequences of twenty-eight leptospiral 
strains, including pathogenic, non-pathogenic and 
intermediate strains. Statistical analysis of three 
pathogenic genomospecies revealed peak differences 
at the species level in this study (Rettinger et al., 
2012). Zhang (2015) used the 16S rRNA sequencing 
and MLST genotyping methods to investigate the 
genetic diversity of pathogenic Leptospira and 
understand the changing epidemiological and 
evolutionary trends of this serogroup in Mainland 
China. Their data revealed that the major Leptospira 
species from different countries were distinct and 
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had great genetic diversity in geographic 
epidemiology (Wang et al., 2006). Bourhy (2014) 
was inferred from sequence analysis of the 16S 
rRNA gene and analyzed the phylogenetic of the 
genus Leptospira in Mayotte (Indian Ocean). These 
data were phylogenetically consistent and reflected 
genetic relatedness among species of these genus 
Leptospira (Bourhy et al., 2014). Our present study 
also indicated that 16S rRNA gene sequencing is a 
useful technique to explore the genetic diversity and 
molecular epidemiology of leptospirosis on a global 
and/or historical scale. Moreover, these results 
provide a blueprint for further phylogenetic research 






































Checking for some antigenic genes in Vietnamese 
pathogenic Leptospira serovars  
 In an effort to find the promising antigenic genes 
for launching a kind of recombination leptospirosis 
vaccines in Vietnam, we selected six genes (e.g. 
LigA, LigB, OmpL1, LipL32, LipL41 and LipL21 
genes) and checked gene expression in these 
Leptospira strains by PCR method. Only three genes 
(e.g., LipL32, LipL21, and LigA genes) were 
expressed in all strains and OmpL1 gene occured in 
four strains (L.Bataviae_VN, L.Canicola_VN, 
L.Grypothyphosa_VN and L.Mitis_VN), whereas 
LipL41 and LigB genes did not appear in any 
Leptospira strains (data not shown) (Figure 2).  
 It has long been expected to find an effective 
vaccine to prevent leptospirosis through 
Figure 1. Phylogenetic analysis based on based on 16S rRNA gene for the thirty pathogenic Leptospira strains (twenty-four 
sequences obtained from the NCBI database). Phylogenetic trees were constructed by Maximum likelihood and Neighbour-
joining method. The bootstrap percentages quoted are the percentage times a taxa at that node occurred. The scale bar 
represents the number of base pairs differences. The arrows (à) indicate Leptospira strains in Vietnam. 
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immunization of high risk humans or animals. 
Although some leptospirosis vaccines have been 
obtained, the vaccination is relatively unsuccessful 
and millions of dollars spent (Wang et al., 2007). In 
Vietnam, mainly using inactivated vaccine in 
preventing and controlling leptospirosis. However, 
vaccination with inactivated whole-cell preparations 
(bacterins) has limited efficacy due to the wide 
antigenic variation of the pathogen. A intensive 
efforts towards developing improved recombinant 
vaccines are ongoing. During the last decade, many 
reports on the evaluation of recombinant vaccines 
have been published. Partial success has been 
obtained with some surface exposed protein 
antigens. Raja (2013) was surveyed the different 
types of OMPs of Leptospira and combines all the 
novel features of OMPs and put forth some views for 
future research (Raja, Natarajaseenivasan, 2015). 
Forster (2015) evaluated the N-terminal region of the 
leptospiral immunoglobulin-like B protein (LigBrep) 
as a candidate antigen for an effective vaccine 
against leptospirosis and emphasised the use of the 
DNA prime protein boost as an important strategy 
for vaccine development (Forster et al., 2015). Hu 
(2014) reported several outer membrane protein 
antigens exist in all the L. interrogans prevailing in 
China and suggested that predominant T- and B-cell 
combined epitopes in the outer membrane protein 
antigens can be used for developing novel universal 
leptospirosis vaccines (Hu et al., 2014). The research 
results of Dezhbord (2014) in cloning gene for 
expression and recombinant OmpL1 as an efficient 
and conserved antigen were suggested that OmpL1 
gene may be a useful vaccine candidate against 
leptospirosis in Iran region (Dezhbord et al., 2014). 
Several researchers suggested the purified 
recombinant LigA protein is the most promising 
subunit vaccine candidate against leptospirosis 
reported to date, however, as purified proteins are 
weak immunogens the use of a potent adjuvant is 
essential for the success of LigA as a subunit 
vaccine (Bacelo et al., 2014; Kanagavel et al., 
2014). In 2014, Maneewatch and Adisakwattana 
studied two LipL32-specific mouse monoclonal 
antibodies (mAbLPF1 and mAbLPF2) and 
suggested LipL32 recombinant protein as 
diagnostic and vaccine targets for leptospirosis 
(Maneewatch et al., 2014). In addition, Ye (2014) 
was tested and developed four recombinant 
proteins of Leptospira interrogans, namely, 
rLipL21, rLoa22, rLipL32, and rLigACon4-8 as 
antigens for the diagnosis of equine leptospirosis 
(Ye et al., 2014). Although were not 
commercialization, the first vaccines were put 
foundation for efficacy of new generations, which 
have outstanding developments to coincide the 
present needs. However, a crucial work on 
effective recombinant vaccine development and 
engineered antibodies will hopefully meet to solve 























Figure 2. Gene expression products of Leptospira strains. Each species labeled as follow: Ba: L.Bataviae_VN; Ca: L. 
Canicola_VN; Ic: L.Ictero haemohagiae_VN; Gr: L.Grippotyphosa_VN; Mitis: L.Mitis_VN; Pm: L.Pomona_VN; M: Marker 
DNA 1 Kb (10,000 bp; Thermo) or Marker DNA 100 bp (1,000 bp, Thermo).  
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Epitope candidates 
 The potential B cell and T cell epitopes were 
found to be distributed throughout the whole 
sequence, numerous fragments could be selected as 
candidates for the design of a vaccine. Nevertheless, 
it is necessary to define both B cell and T cell 
epitopes as candidates, to thereby generate a vaccine 
inducing both humoral and cellular response. 
Therefore, a more exhaustive analysis was 
performed to identify regions comprising both types 
of epitopes. 
 The combined T and B cell epitopes were 
predicted based on the amino acid sequences of 
LipL21 and LipL32. The LipL21 and LipL32 
translated sequences had 163 and 215 amino acids 
(aa), respectively. Six sequences for each gene were 
aligned by multiple sequence alignment using 
BioEdit software, to obtain the conserved regions. 
The only one different amino acid at amino acid 
114th of LipL32 sequences was detected. Thus one 
conserved regions for the LipL21 and two conserved 
regions for 1-113 aa residues (LipL321-113) and 115-
215 aa residues (LipL32115-215) of LipL32 were 
chosen to predict protein 3D structure and potential 



















 The results of mapping showed that, all of three 
conserved peptides had two high levels of mapped 
epitopes regions. Because, these regions had many 
candidate epitopes positions, they may show the 
higher antigenicity than other regions. They were 
LipL21 residues 2-70 (LipL212-70), LipL2171-119, 
LipL324-61, LipL3281-133, LipL32115-158, and 
LipL32164-210. The six peptide has length in range 45 
- 69 aa (Figure 4). 
 Previous studies recommended that the 
application of only one protein as a subunit 
recombinant vaccine could not successfully prevent 
leptospirosis since it is not antigenic enough to 
stimulate the immune system. While, the applying 
multi-epitope vaccines, which use epitopes of several 
proteins, were the solution to vaccine antigenicity 
(Branger et al., 2001; Haake et al., 1999). Several 
researchers had used in silico approach for 
identifying and designing of vaccine candidates 
(Branger et al., 2001; Hasan et al., 2015; Khatoon et 
al., 2017) and some of them achieved promising 
clinical trial results (Groot, Rappuoli, 2004). Multi-
epitope peptide DNA vaccines are effective against 
some viruses and they have recently been shown to 
have potential efficacy against some bacterial 
diseases including leptospires. Similarly, the fact that 
the DNA was expressed efficiently invitro is 
indicative of the fact that the DNA is 
correspondingly expressed after immunization as 
observed from the protection rendered. However, 
incorporating T-cell epitopes may likely improve the 
potency of the vaccine as Th-1 type immune 
response has previously been demonstrated in cattle 
vaccinated with killed L. Hardjo vaccine (Naiman et 
al., 2001). Overall, the present novel immunogenic 
multi-epitope DNA vaccine developed by chemical 
gene synthesis and delivered as a plasmid DNA 
vaccine may serve as a new candidate target for 
leptospiral vaccine development. 
 In the present study, we also used bioinformatic 
Figure 3. 3D structure of the conservative regions in outer membrane lipoproteins LipL21 and LipL32. Using seven different 
algorithms for B cell and two algorithms for T cell, 95 epitopes from LipL21 peptide, 46 epitopes from LipL321-113 peptide, 
and 78 epitopes from LipL32115-215 peptide were predicted (Table 3). Candidate peptides were mapped to reference to 
determine the epitope density per base of each peptide. 
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tools to predict candidate epitopes. To stimulate 
antigen specific B cell and T cell immune response, 
epitopes were predicted for both B-cell antibody and 
T-cell MHC (I and II class) (Forouharmehr, Nassiry, 
2015; Yousefi et al., 2015). The six peptide LipL212-
70, LipL2171-119, LipL324-61, LipL3281-133, LipL32115-
158, and LipL32164-210 did not only have the high 
antigenicity but also short enough for recombination. 
Therefore, with further test, these peptides can be 
candidates for a new recombinant vaccine for 
designing a recombinant multi-epitope vaccine 
















































Figure 4. Antigenic epitope prediction showing potential B and T cell epitopes for LipL21 (A), LipL321-113  (B), and  LipL32115-
215 (C). 
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Table 3. Number of antigenic epitopes in the conservative regions of outer membrane lipoproteins LipL21 and LipL32. 
 
 Number of epitope 
 LipL21 LipL321-113 LipL32115-215 
Tc cell (Cytotoxic T cell) 53 18 45 
Th cell  (T helper cells) 19 10 19 
B cell 23 14 14 
  
CONCLUSION 
 From the initial research results, we suggested 
that the six Vietnamese L. interrogan strains were 
differentiated effectively in genetical distance by 
phylogenetic analysis.  Moreover, three genes 
(LipL32, LipL21, and LigA genes) were expressed in 
six Vietnamese pathogenic strains of Leptospira. 
This work identified combined T and B cell 
immunodominant epitopes in LipL32 and LipL21 of 
L. interrogans. The identification of these immune 
dominant epitopes may greatly facilitate the 
development of novel leptospiral vaccines which 
may provide protections across different serogroups 
or serovars. The findings could also contribute to the 
development of effective cross-protective vaccine 
strategies for againsting leptospirosis in Vietnam. 
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PHÂN TÍCH TRÌNH TỰ GEN 16S rRNA TỪ CÁC CHỦNG LEPTOSPIRA GÂY BỆNH 
CỦA VIỆT NAM VÀ DỰ ĐOÁN IN-SILICO CÁC EPITOPE TIỀM NĂNG TRÊN HAI 
LIPOPROTEIN MÀNG NGOÀI LIPL21, LIPL32 
 
Võ Thị Bích Thuỷ1,2, Nguyễn Tuấn Hùng2,3, Nghiêm Ngọc Minh2 
1Viện Nghiên cứu hệ gen, Viện Hàn lâm Khoa học và Công nghệ Việt Nam  
2Học viện Khoa học và Công nghệ, Viện Hàn lâm Khoa học và Công nghệ Việt Nam  
3Công ty Cổ phần Thuốc Thú y Trung ương VETVACO, Đức Thượng, Hoài Đức, Hà Nội 
TÓM TẮT 
 Bệnh xoắn khuẩn (Leptospirosis) được xác định là một bệnh truyền nhiễm mới nổi, có khả năng gây bệnh 
trên động vật và lây lan sang người. Bệnh do Leptospira gây ra. Mặc dù đã có một số loại vacxin phòng bệnh 
do Leptospira nhưng đáp ứng miễn dịch không cao, thời gian bảo hộ không dài. Trong thí nghiệm này, một 
đoạn 550 bp của gen RNA ribosome (16S rRNA) của 6 chủng Leptospira gây bệnh xoắn khuẩn và đang được 
sử dụng làm chủng chế vacxin vô hoạt ở Việt Nam (bao gồm: Pomona, Canicola, Mitis, Ictero haemohagiae, 
Bataviae, và Grippotyphosa) đã được giải trình tự. Kết quả cho thấy một mối quan hệ di truyền gần gũi của 
chủng L.Pomona_VN với L.Hardjo (bootstrap: 99%). Ngược lại, L.Canicola_VN và L.Ictero haemohagiae_VN 
dường như có mối quan hệ di truyền yếu với các chủng cổ điển L.Canicola, L. Grippotyphosa (bootstrap: 62%). 
Các chủng khác như L.Mitis_VN và L.Grippotyphosa_VN xuất hiện cùng nhánh, nhưng lại có mối quan hệ di 
truyền yếu với nhóm chị em của chúng là chủng L.Bataviae_VN (bootstrap: 62%). Chúng tôi cũng lựa chọn 6 
gen, gồm: các globulin miễn dịch như protein A và B (gen LigA và LigB), protein màng ngoài (gen OmpL1), và 
lipopolysaccharide (gen LipL32, LipL41 và LipL21) để kiểm tra sự xuất hiện của các gen này ở các chủng 
Leptospira trên bằng phương pháp phản ứng chuỗi polymerase (PCR). Có 3 gen (gen LipL32, LipL21 và LigA) 
xuất hiện trong tất cả các chủng, riêng gen OmpL1 chỉ có ở 4 chủng (Bataviae, Canicola, Grypothyphosa và 
Mitis), trong khi đó gen LipL41 và LigB đã không xuất hiện trong bất kỳ chủng Leptospira nào. Một tập hợp 
các epitope tiềm năng trong cả tế bào lympho T và B của protein LipL21 và LipL32 đã được tìm kiếm bằng 
các công cụ tin sinh. Kết quả chỉ ra, có 3 vùng đa epitope (1 vùng và 95 epitope kháng nguyên cho cả hai tế 
bào B và T của LipL21; 2 vùng và 124 epitope kháng nguyên cho cả hai tế bào B và T của LipL32). Cần 
nghiên cứu sâu hơn về sinh học phân tử để tạo ra được một loại vac xin tái tổ hợp mới ứng dụng trong phòng 
và điều trị bệnh leptospirosis cho động vật và người ở Việt Nam.  
Từ khóa: Gen quyết định kháng nguyên, Loài Leptospira, Vacxin tái tổ hợp leptospirosis, Trình tự gen 16S rRNA  
 
